The Austin Technology Incubator harnesses business, government and academic resources to provide strategic counsel, operational guidance, and infrastructure support to its member companies to help them transition into successful, high growth technology businesses.
Since its founding in 1989, ATI has worked with over 200 companies, helping them raise over $1 billion in investor capital. Over the past five years, including the “Great Recession,” ATI has worked with over 100 companies, helping them to raise over $250 million in investor capital. During that same 5-year period, ATI alumni companies realized approximately $400 million in exit value. Roughly 75% of companies admitted into ATI receive external funding.
ATI is committed to working with the best founding teams in Austin. Out of an annual “pipeline” of 100-150 prospective companies, ATI typically admits only 5-10 into membership in the incubator. Investors, executive talent, and mentors recognize this selectivity.
ATI is a program of the IC² Institute of The University of Texas at Austin. It has a dual mission: promote economic development in Central Texas through entrepreneurial wealth and job creation, and provide a “teaching laboratory” in applied entrepreneurship for UT-Austin students. ATI works closely with other commercially-focused and business-building programs at The University.
Although ATI is part of The University of Texas at Austin, there is no requirement that ATI companies need to be based on UT-Austin technology, or indeed have any formal connection to The University other than ATI membership.
ATI’s Bioscience program focuses on human health – medical devices, diagnostics, research tools, and therapeutics. The Bio team has deep expertise in the regulatory pathways and reimbursement landscapes that human health-focused start-ups have to navigate.
Founded in 2008 in partnership with the City of Austin, ATI-Bioscience works closely with other members of the Central Texas and statewide bioscience ecosystem, including BioAustin, Austin Life Science Entrepreneurs, local medical centers, and more. The ATI-Bioscience team has also invested in building relationships with life sciences funders, including specialist venture capital firms (both inside and outside Texas,) the Emerging Technology Fund, Cancer Prevention and Research Institute Texas, and others.